Back
46
61
Day Range
$350.76
$358.00
52-Week Range
$261.43
$391.29
Volume
1,831,434
50D / 200D Avg
$359.42
/
$316.58
Prev Close
$348.43
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 24.7 | 0.2 |
| P/B | 22.0 | 3.0 |
| ROE % | 106.1 | 3.6 |
| Net Margin % | 21.0 | 3.8 |
| Rev Growth 5Y % | 9.1 | 10.0 |
| D/E | 6.3 | 0.2 |
Analyst Price Target
Hold
$347.73
-1.8%
Low: $185.00
High: $432.00
Forward P/E
15.80
Forward EPS
$22.41
EPS Growth (est.)
+0.0%
Est. Revenue
37.84B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$27.53
$26.56 – $29.06
|
42.75B | 4 |
| FY2029 |
$25.48
$24.59 – $26.90
|
41.40B | 4 |
| FY2028 |
$24.22
$18.95 – $32.36
|
39.77B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-03 | $4.73 | $5.29 | +11.8% |
| 2025-11-04 | $5.02 | $5.64 | +12.4% |
| 2025-08-05 | $5.28 | $6.02 | +14.0% |
| 2025-05-01 | $4.27 | $4.90 | +14.8% |
| 2025-02-04 | $5.04 | $5.31 | +5.4% |
| 2024-10-30 | $5.11 | $5.58 | +9.2% |
| 2024-08-06 | $4.98 | $4.97 | -0.2% |
| 2024-05-02 | $3.88 | $3.96 | +2.1% |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 |
Santos Esteban
EVP, Operations
|
other | 5,621 | $366.21 | $2,058,466.41 |
| Mar 16, 2026 |
Gordon Murdo
EVP, Global Commercial Ops
|
other | 6,691 | $366.21 | $2,450,311.11 |
| Mar 16, 2026 |
Graham Jonathan P
EVP & Gen. Counsel & Sec.
|
other | 5,353 | $366.21 | $1,960,322.13 |
| Mar 16, 2026 |
Miller Derek
SVP, Human Resources
|
other | 1,616 | $366.21 | $591,795.36 |
| Mar 3, 2026 |
REESE DAVID M
EVP & Chief Technology Officer
|
grant | 12,063 | — | — |
| Mar 3, 2026 |
Grygiel Nancy A.
SVP & CCO
|
grant | 2,010 | — | — |
| Mar 3, 2026 |
Miller Derek
SVP, Human Resources
|
grant | 3,484 | — | — |
| Mar 3, 2026 |
Khosla Rachna
SVP, Business Development
|
grant | 1,876 | — | — |
| Feb 19, 2026 |
Busch Matthew C.
VP, Finance & CAO
|
sell | 1,000 | $375.79 | $375,790.00 |
| Nov 12, 2025 |
Khosla Rachna
SVP, Business Development
|
sell | 890 | $336.24 | $299,255.56 |
| Aug 8, 2025 |
HOLLEY CHARLES M
Director
|
grant | 147 | — | — |
| Aug 8, 2025 |
ISHRAK OMAR
Director
|
grant | 121 | — | — |
| May 23, 2025 |
Jacks Tyler
Director
|
grant | 809 | — | — |
| May 23, 2025 |
ECKERT ROBERT
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Garland Greg C.
Director
|
grant | 809 | — | — |
| May 23, 2025 |
Austin Wanda M
Director
|
grant | 809 | — | — |
| May 6, 2025 |
ISHRAK OMAR
Director
|
grant | 129 | — | — |
| May 6, 2025 |
Busch Matthew C.
VP, Finance & CAO
|
grant | 4,139 | — | — |
| May 2, 2025 |
Bradway Robert A
Chairman, CEO and President
|
other | 4,833 | $283.78 | $1,371,508.74 |
| May 2, 2025 |
Griffith Peter H.
EVP & CFO
|
other | 1,367 | $283.78 | $387,927.26 |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.66%
Growth (3Y)
7.05%
Growth (5Y)
8.27%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 15, 2026 | Jun 05, 2026 | $2.52 | 2.77% |
| Feb 13, 2026 | Mar 06, 2026 | $2.52 | 2.62% |
| Nov 21, 2025 | Dec 12, 2025 | $2.38 | 2.82% |
| Aug 22, 2025 | Sep 12, 2025 | $2.38 | 3.20% |
| May 16, 2025 | Jun 06, 2025 | $2.38 | 3.40% |
| Feb 14, 2025 | Mar 07, 2025 | $2.38 | 3.14% |
| Nov 18, 2024 | Dec 09, 2024 | $2.25 | 3.23% |
| Aug 16, 2024 | Sep 06, 2024 | $2.25 | 2.76% |
| May 16, 2024 | Jun 07, 2024 | $2.25 | 2.78% |
| Feb 15, 2024 | Mar 07, 2024 | $2.25 | 2.99% |
| Nov 16, 2023 | Dec 08, 2023 | $2.13 | 3.17% |
| Aug 17, 2023 | Sep 08, 2023 | $2.13 | 3.16% |
| May 17, 2023 | Jun 08, 2023 | $2.13 | 3.62% |
| Feb 14, 2023 | Mar 08, 2023 | $2.13 | 3.30% |
| Nov 16, 2022 | Dec 08, 2022 | $1.94 | 2.73% |
| Aug 17, 2022 | Sep 08, 2022 | $1.94 | 3.02% |
| May 16, 2022 | Jun 08, 2022 | $1.94 | 3.03% |
| Feb 14, 2022 | Mar 08, 2022 | $1.94 | 3.22% |
| Nov 15, 2021 | Dec 08, 2021 | $1.76 | 3.39% |
| Aug 16, 2021 | Sep 08, 2021 | $1.76 | 2.98% |
Key Takeaways
Revenue grew 9.05% annually over 5 years — modest growth
Earnings grew 88.53% over the past year
ROE of 106.10% indicates high profitability
Net margin of 20.99% shows strong profitability
Debt/Equity of 6.31 — high leverage
Generating 8.10B in free cash flow
Growth
Revenue Growth (5Y)
9.05%
Revenue (1Y)9.92%
Earnings (1Y)88.53%
FCF Growth (3Y)4.91%
Quality
Return on Equity
106.10%
ROIC12.66%
Net Margin20.99%
Op. Margin29.06%
Safety
Debt / Equity
6.31
Current Ratio1.14
Interest Coverage3.88
Valuation
P/E Ratio
24.74
Forward P/E15.80
P/B Ratio22.04
EV/EBITDA22.13
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.92% | Revenue Growth (3Y) | 14.16% |
| Earnings Growth (1Y) | 88.53% | Earnings Growth (3Y) | 7.14% |
| Revenue Growth (5Y) | 9.05% | Earnings Growth (5Y) | 6.95% |
| Profitability | |||
| Revenue (TTM) | 36.74B | Net Income (TTM) | 7.71B |
| ROE | 106.10% | ROA | 8.51% |
| Gross Margin | 70.80% | Operating Margin | 29.06% |
| Net Margin | 20.99% | Free Cash Flow (TTM) | 8.10B |
| ROIC | 12.66% | FCF Growth (3Y) | 4.91% |
| Safety | |||
| Debt / Equity | 6.31 | Current Ratio | 1.14 |
| Interest Coverage | 3.88 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.66% |
| Dividend Growth (3Y) | 7.05% | Dividend Growth (5Y) | 8.27% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24.74 | Forward P/E | 15.80 |
| P/B Ratio | 22.04 | P/S Ratio | 5.19 |
| PEG Ratio | 0.26 | Forward PEG | N/A |
| EV/EBITDA | 22.13 | Fwd EV/EBITDA | 13.86 |
| Forward P/S | 5.04 | Fwd Earnings Yield | 6.33% |
| FCF Yield | 4.25% | ||
| Market Cap | 190.79B | Enterprise Value | 236.27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36.74B | 33.42B | 28.19B | 26.32B | 25.98B |
| Net Income | 7.71B | 4.09B | 6.72B | 6.55B | 5.89B |
| EPS (Diluted) | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 |
| Gross Profit | 26.01B | 20.57B | 19.78B | 19.92B | 19.53B |
| Operating Income | 10.68B | 7.26B | 7.90B | 9.57B | 7.64B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.59B | 91.84B | 97.15B | 65.12B | 61.17B |
| Total Liabilities | 81.93B | 85.96B | 90.92B | 61.46B | 54.47B |
| Shareholders' Equity | 8.66B | 5.88B | 6.23B | 3.66B | 6.70B |
| Total Debt | 54.60B | 60.10B | 64.61B | 38.95B | 33.31B |
| Cash & Equivalents | 9.13B | 11.97B | 10.94B | 7.63B | 7.99B |
| Current Assets | 29.06B | 29.03B | 30.33B | 22.19B | 19.39B |
| Current Liabilities | 25.49B | 23.10B | 18.39B | 15.69B | 12.18B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#84 of 220
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#91 of 327
Recent Activity
Entered
Capital Light Compounder
Mar 24, 2026
Entered
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026